Picture courtesy The Indian Express
Pune: The Serum Institute of India (SII) is gearing up to launch another COVID-19 vaccine – Covovax, which is developed in partnership with America’s Novavax.
CEO Adar Poonawalla is hopeful of launching the vaccine by September this year. He notified that the vaccine has been tested against UK and African variants of the virus and has an efficacy of 89 per cent.
SII is conducting phase 2 and 3 bridging study of 1,600 participants for this vaccine.
This COVID-19 vaccine will be SII’s second in India. It is already supplying Covishield – made by Oxford University in collaboration with AstraZeneca.
There is speculation that the Russian vaccine Sputnik V which is currently being made by five firms in India, will be the next vaccine to be approved here. It has an efficacy of 91.6 per cent.
Also Read: COVID-19: Sputnik V To Be Made By 5 Firms In India
Stay ahead with Odisha Bytes Breaking News - your ultimate source for the fastest, most…
New Delhi: After the record-breaking success of ‘Pushpa 2: The Rule’, Rashmika Mandanna has her…
Bhubaneswar: Twelve members of Village Water and Sanitation Committees (VWSC) from nine districts of Odisha…
Hyderabad: Bollywood actress Janhvi Kapoor, who is rumoured to be dating Shikhar Pahariya, had once…
Bhubaneswar: In a remarkable stride toward strengthening industrial ecosystem, the Odisha government on Wednesday approved…
Bengaluru: Playing away from home, Odisha FC turned the game on its head to snatch a…
This website uses cookies.
